Skip to main content
All lobbying filings

HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA)

HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) filed a Q3 report for HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) on October 14, 2026.

Lobbying for HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA)

All filings by HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) · Everything HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 14, 2026
Expenses
$545,610
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Virginia

Official filing document

 Government bodies contacted 7

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Pharmacy

General Issues Related to report language regarding paper inserts H.R. 2853, Combating Organized Retail Crime Act Education around issues facing pharmacies, including Main Street Pharmacy Access Act (H.R. 3164)

Health Issues

General Issues Related to Drug Shortages including Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile General Issues Related to Pharmaceutical Supply Chain General Issues Related to Proposed Physician Fee Schedule Rule Education around issues facing independent physicians, including S. 3822, the Break Up Big Medicine Act S.3315 and House draft, Healthcare Cybersecurity and Resiliency Act

 Bills named in this filing 4
  • H.R. 2853
    Combating Organized Retail Crime Act of 2025
  • H.R. 3164
    Ensuring Community Access to Pharmacist Services Act
  • S. 3822
    Break Up Big Medicine Act
  • S. 3315
    Health Care Cybersecurity and Resiliency Act of 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem